0001209191-21-036259.txt : 20210527 0001209191-21-036259.hdr.sgml : 20210527 20210527163915 ACCESSION NUMBER: 0001209191-21-036259 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210527 FILED AS OF DATE: 20210527 DATE AS OF CHANGE: 20210527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Breeden Richard C CENTRAL INDEX KEY: 0001300622 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38848 FILM NUMBER: 21973337 MAIL ADDRESS: STREET 1: 100 SOUTH WACKER STREET 2: SUITE 1800 CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STERIS plc CENTRAL INDEX KEY: 0001757898 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 70 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 35312322000 MAIL ADDRESS: STREET 1: 70 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: STERIS Ltd DATE OF NAME CHANGE: 20181101 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-27 0 0001757898 STERIS plc STE 0001300622 Breeden Richard C C/O 70 SIR JOHN ROGERSON'S QUAY DUBLIN L2 2 IRELAND 1 0 0 0 Ordinary Shares 2021-05-27 4 M 0 3121 31.61 A 34802 D Ordinary Shares 27242 I See Footnotes Below Employee Stock Option (right to buy) 31.61 2021-05-27 4 M 0 3121 0.00 A 2021-08-03 Ordinary Shares 3121 0 D Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney 2021-05-27